Public COA audit

Limulus Amebocyte Lysate (LAL) · LL-37

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
1/7

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
16-3-45954
Sample date
2025-11-19
Issue date
2025-11-19

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

1 of 7 present · 1 passed · 0 failed · 0 reported · 6 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Not on this COA · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Purity

    Not on this COA · core

    Reported purity percentage for the analyte.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    < 0.050 EU/mL

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • Endotoxin testing performed

    Endotoxin level measured at < 0.050 EU/mL, well below the acceptable threshold of 0.25 EU/mL. Test passed using Endosafe-PTS LAL Assay method.

  • Limited testing scope

    This COA only reports endotoxin testing. No identity, purity, heavy metals, microbial, sterility, or residual solvent testing is included. This is a specialized endotoxin-only report, not a comprehensive peptide COA.

  • Batch information present

    Sample lot number 16-3-45954 clearly documented with sample concentration (5 mg) and company name (Biolongevity Labs).

  • Test date documented

    Test date and analyst signature date both recorded as 11/19/2025, which is consistent and within acceptable range.

  • Lab identification and verification

    BioRegen lab clearly identified with contact information ([email protected], www.bioregen.com), Report ID (BL-ENDO-251911-176), Validation Key (BIOLABS2010), and QR code for verification.

  • Professional presentation

    Document follows standard laboratory report format with clear sections, proper headers, analyst signature, and verification instructions.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.